CureVac

Photo: BSS/AFP
Coronavirus chronicle

Covid vaccine from Germany's CureVac just 48% effective: final results

The European Union has secured up to 405 million doses of the CureVac vaccine

Representational Image. Photo: Reuters
Coronavirus chronicle

CureVac crashes after crucial Covid-19 vaccine trial disappoints

Representational Image. Photo: Reuters
Coronavirus chronicle

CureVac says mass vaccine rollout thrown into doubt by US restrictions

Representational Image. Photo: Reuters
Coronavirus chronicle

CureVac starts review process in Switzerland for Covid-19 vaccine hopeful

Representational Image. Photo: Reuters
Coronavirus chronicle

CureVac's Covid-19 vaccine attracts rising interest

Representational Image. Photo: Reuters
Coronavirus chronicle

CureVac says aiming for pivotal vaccine trial read-out early in Q2

Representational Image. Photo: Reuters
Coronavirus chronicle

CureVac says preliminary trials show Covid-19 vaccine effective against variants

Representational Image. Photo: Reuters
Coronavirus chronicle

GSK, CureVac say to develop vaccine targeting Covid variants

Representational Image. Photo: Reuters
Coronavirus chronicle

Bayer and Rentschler to help produce CureVac's Covid-19 shot

Representational Image. Photo: Reuters
Coronavirus chronicle

Bayer aims to help CureVac with Covid-19 vaccine output, says CEO

Representational Image. Photo: Reuters
Coronavirus chronicle

CureVac strikes Covid-19 vaccine alliance with Bayer

Photo: Collected.
Coronavirus chronicle

EU could pay over $10 billion for Pfizer and CureVac vaccines 

Representational Image. Photo: Reuters
World+Biz

CureVac hiking capacity to 300 million Covid-19 doses in 2021